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The gene for the atypical NOTCH ligand delta-like homologue 1 (Dlk1) encodes membrane-bound and secreted isoforms that function in several developmental processes in vitro and in vivo. Dlk1, a member of a cluster of imprinted genes, is expressed from the paternally inherited chromosome 1, 2 . Here we show that mice that are deficient in Dlk1 have defects in postnatal neurogenesis in the subventricular zone: a developmental continuum that results in depletion of mature neurons in the olfactory bulb. We show that DLK1 is secreted by niche astrocytes, whereas its membrane-bound isoform is present in neural stem cells (NSCs) and is required for the inductive effect of secreted DLK1 on self-renewal. Notably, we find that there is a requirement for Dlk1 to be expressed from both maternally and paternally inherited chromosomes. Selective absence of Dlk1 imprinting in both NSCs and niche astrocytes is associated with postnatal acquisition of DNA methylation at the germ-line-derived imprinting control region. The results emphasize molecular relationships between NSCs and the niche astrocyte cells of the microenvironment, identifying a signalling system encoded by a single gene that functions coordinately in both cell types. The modulation of genomic imprinting in a stem-cell environment adds a new level of epigenetic regulation to the establishment and maintenance of the niche, raising wider questions about the adaptability, function and evolution of imprinting in specific developmental contexts.
The mammalian adult brain is generally postmitotic, but reservoirs of NSCs with features of astroglial cells exist in the hippocampus and subventricular zone (SVZ), supporting lifelong neurogenesis 3, 4 . The SVZ is a very active germinal niche in which production of neurons occurs via a transit-amplifying progenitor population 4 , giving rise to migrating neuroblasts that integrate into the circuitry of the olfactory bulb 5 . The specialized microenvironment containing niche astrocytes regulates long-term maintenance of NSCs and ensures continual neurogenesis 3, 4, 6 . An emerging hypothesis is that NSCs and niche astrocytes are established in the postnatal radial glia/astrocytic lineage 7 ; however, the potential lineage relationships and cell-cell interactions between them are not completely understood [6] [7] [8] . Dlk1 encodes a transmembrane protein belonging to the Notch/ Delta/Serrate family of signalling molecules, which have key roles in differentiation [9] [10] [11] . Dlk1 is widely expressed during embryonic development [12] [13] [14] and is dosage-sensitive, with overexpression causing phenotypes ranging from prenatal lethality to defects in postnatal energy homeostasis 15 . Few tissues retain Dlk1 expression postnatally and deletion experiments have demonstrated in vivo functions for DLK1 in adipogenesis and haematopoiesis 10, 11, 16 . We detected DLK1 in neurogenic areas of the prenatal telencephalon and in the postnatal SVZ, with a peak at postnatal day 7 (P7). In the adult brain, Dlk1 expression is mainly restricted to neurons of several areas, including the ventral tegmental area 14 , the septum and the ventral striatum, but the protein is still detected in specific cell types of the mature SVZ, in particular NSCs (GFAP Fig. 1a-j) .
To test for potential roles for DLK1 in neurogenesis, we analysed brain germinal regions in embryos and postnatal mice with a targeted mutation in the Dlk1 gene 11 . Although we observed expression of DLK1 both in progenitor cells and in differentiating neurons in ganglionic eminences at embryonic day (E)12.5 and E14.5, we did not observe any differences between Dlk1-wild-type and mutant embryos in progenitor-cell activity or in neurogenesis in the mantle (Supplementary Fig. 2a-c) , indicating that DLK1 is dispensable during embryonic neurogenesis. In contrast, we observed increased activity of NSCs in the developing SVZ at P7, indicated by higher numbers of GFAP 1
MKI67
1 cells. This resulted in increased numbers of doublecortin (DCX) 1 neuroblasts (Fig. 1a, b and Supplementary Fig. 3a ), indicating a failure to maintain the slower-dividing stem-cell pool in the postnatal SVZ.
Postnatal day 7 is a transition time point between development of the embryonic germinal layer and the mature SVZ 17 , so we next evaluated adult mice. Wild-type and Dlk1-mutant mice at P60 were injected with 5-bromo-2-deoxyuridine (BrdU) and killed one month later to assess BrdU-label-retaining cells (LRCs). LRCs mark relatively quiescent NSCs and cells that abandon the cell cycle shortly after labelling, such as terminally differentiated cells in the SVZ and newly-formed olfactory-bulb neurons 18 . The numbers of BrdU
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1 cells were significantly reduced in Dlk1 2/2 mice (Fig. 1c, d and Supplementary Fig. 3b ). However, the percentage of GFAP 1
MKI67
1 cells was similar in both genotypes ( Supplementary  Fig. 3d, f) , indicating a change in NSC number but not in their cycling parameters. Fewer NSCs resulted in a smaller ASCL1 (also known as MASH1)
1 transit-amplifying progenitor population and fewer DCX 1 neuroblasts ( Supplementary Fig. 3c , e, f), resulting in a less densely populated rostral migratory stream (Fig. 1e) . Moreover, the numbers of postmitotic calretinin (CALB2) 1 and tyrosine hydroxylase (TH) 1 newly formed BrdU 1 neurons in the granular and periglomerular layers of the mutant olfactory bulb were significantly reduced ( Supplementary  Fig. 3g ).
It has been demonstrated that disruption of quiescence at early postnatal periods leads to loss of stem-cell potential and depletion of the NSC pool later in life 19, 20 . To test whether DLK1 was indeed required for NSC maintenance, we evaluated the size of the stem-cell pool over time by determining the yield of primary neurospheres at different ages. A transiently higher yield of primary neurospheres from P7 SVZ mutant tissue was followed by an increase in their progressive decline as the animals aged (Fig. 1f) , indicating that postnatal expression of DLK1 is required for life-long maintenance of the NSC pool.
To evaluate dosage effects of the Dlk1 gene, mice carrying the mutation on the maternally inherited (Dlk1 
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1 LRCs and of newly generated olfactory bulb neurons were reduced in both Dlk1 heterozygotes ( Fig. 1d and Supplementary Fig. 3g) . Consistent with the defects observed in vivo, the SVZ from Dlk1
1/2 and Dlk1 2/2 mice all yielded markedly fewer primary neurospheres than wild-type tissue, although brain size was normal (Fig. 1g and Supplementary Fig. 3h, i) . We confirmed that these phenotypes were specifically due to a reduction in the available levels of DLK1 by generating paternal-transmission Dlk1 mutants that were also hemizygous for a Dlk1-expressing transgene (Dlk1 (Fig. 1d, g ).
Despite being reduced in number, mutant neurospheres displayed normal clonogenic capacity upon passage (Fig. 2a) , indicating that DLK1 acts as a postnatal niche-secreted factor in vivo. Treatment of P7 and P60 cultures with recombinant mouse DLK1 resulted in 40-50% more neurospheres (Fig. 2b) , and markedly higher numbers of secondary spheres were formed from primary neurospheres that had been grown (pre-treated) in DLK1-supplemented medium (Supplementary Fig. 4a ). These increases were not due to DLK1 promoting NSC survival ( Supplementary Fig. 4b ), indicating that the addition of DLK1 specifically increased self-renewing symmetrical divisions. Moreover, multipotentiality in clonal differentiation assays was increased by exogenous DLK1 (Fig. 2c ), further supporting a role for DLK1 as a niche factor. To evaluate this further, we co-cultured astrocytes acutely isolated from the SVZ of wild-type, Dlk1
and Dlk1 2/2 P7 and P60 mice 8 with wild-type NSCs, using transwell inserts (Fig. 2d) . Wild-type niche astrocytes induced a marked increase in neurosphere formation which was abrogated when niche astrocytes were derived from Dlk1 mutants (Fig. 2d, e) . The reduction in neurosphere number in medium conditioned with Dlk1 2/2 astrocytes was rescued by the exogenous addition of recombinant DLK1 (Fig. 2f) : an indication that DLK1 secreted by SVZ niche astrocytes regulates NSC self-renewal, probably in combination with other niche factors.
Alternatively spliced transcripts of Dlk1 (Fig. 3a) , encoding protein isoforms that are either membrane-tethered or proteolytically cleaved and secreted, have been described 21 . The secreted isoforms DLK1A and DLK1B contain a juxtamembrane motif for cleavage by extracellular proteases that is absent from membrane-bound DLK1C and DLK1D (Fig. 3a) . Secreted isoforms represent the predominant type in acutely isolated niche astrocytes. Membrane-bound isoforms are preferentially expressed by P7 and P60 NSCs (Fig. 3b) . Notably, exogenously added DLK1 or co-culture with niche astrocytes did not increase neurosphere formation in Dlk1 2/2 NSC cultures ( Fig. 2b , e), indicating that the membrane-tethered form of DLK1 in NSCs contributes to the response to soluble DLK1.
To confirm whether membrane-bound DLK1 is required for the response to soluble DLK1, GFP-tagged vectors expressing membranebound (MB-DLK1) or secreted (S-DLK1) isoforms were nucleofected into Dlk1 1/1 and Dlk1 2/2 NSCs, and neurosphere formation in response to exogenous DLK1 was determined. Dlk1 2/2 NSCs regained the response to exogenous DLK1 only when expressing the membrane-bound isoform ( Fig. 3c and Supplementary Fig. 4c, d ). Furthermore, expression of S-DLK1 but not MB-DLK1 in Dlk1 2/2 niche astrocytes rescued the wild-type NSC response in co-cultures ( Fig. 3c ), indicating that membrane-bound DLK1 in NSCs is stimulated by secreted DLK1. Notably, increased expression of Dlk1 above wild-type levels did not influence the response of NSCs ( Fig. 3c and Supplementary Fig. 4e ). It is worth noting that responses elicited by Jagged 1 (ref. 22) and SERPINF1 (also known as PEDF) 23 are unperturbed in Dlk1-mutant NSCs. Moreover, no change was observed in NOTCH activity after addition of recombinant DLK1 to wild-type NSCs, indicating a NOTCH-independent role for DLK1 (Supplementary Fig. 5a-d) .
Dlk1, which is canonically expressed from the paternally inherited chromosome, belongs to the Dlk1-Dio3 imprinted gene cluster on mouse chromosome 12. Northern blots of RNA from the adult brain confirmed Dlk1 transcription from the paternal allele ( Supplementary  Fig. 6a ). Moreover, we found very low levels of expression of maternal ). e, Whole-mounts for DCX 1 migrating neuroblasts in the SVZ. f, Numbers of primary spheres from wild-type and Dlk1-mutant SVZs at different developmental stages. g, Numbers of primary spheres from the adult SVZ of different Dlk1 mutants. *, P , 0.05; **, P , 0.01; ***, P , 0.001. All error bars show s.e.m. of five experiments (n 5 4 cultures per genotype). Scale bars: a, c, 20 mm (inset, 10 mm); e, 200 mm.
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Dlk1 in paternal heterozygotes, supporting canonical expression from the paternal allele in septal neurons and ventral striatum (Supplementary Fig. 6b, c) NSCs and niche astrocytes, indicating activity from both parental alleles in the neurogenic population (Fig. 4a) . We therefore assayed Dlk1 imprinting in wild-type postnatal mice and adult F 1 hybrid offspring from reciprocal crosses of Mus musculus domesticus (C57BL6/J) and Mus musculus castaneus (CAST/EiJ) ( Supplementary Fig. 6d ). SVZ tissue from reciprocal hybrids showed the expected paternal expression of Dlk1, whereas neurospheres and niche astrocytes showed biallelic expression of both membrane-bound and secreted isoforms ( Fig. 4b and Supplementary  Fig. 6e ). Importantly, other imprinted genes, such as the adjacent Gtl2 gene (also known as Meg3) and Snrpn on chromosome 7C, maintained imprinting in NSCs and niche astrocytes (Fig. 4c) . To determine whether biallelic expression was reflected in DLK1 protein levels in vivo, immunostaining of DLK1 in combination with GFAP and SOX2 was performed on maternal and paternal heterozygotes. This confirmed that there was expression of DLK1 from both parental chromosomes in the NSCs of the neurogenic zone (Fig. 4d, e) . In contrast, postmitotic neurons in non-neurogenic regions showed clear imprinting of Dlk1 ( Supplementary Fig. 6b, c) . Dlk1 was canonically imprinted in NSCs or astrocytes derived from the SVZ of E14.5 embryonic and newborn mice, becoming biallelic by P7 (Supplementary Fig. 6f ). These data demonstrate specific and selective absence of Dlk1 imprinting in the NSC and niche astrocyte populations, commencing at postnatal stages and continuing into adulthood. This indicates that the mechanism conferring postnatal biallelic expression can override the imprint specifically and selectively at Dlk1, and that this regulation is required for normal neurogenesis.
Dlk1-Dio3 domain imprinting is controlled by the intergenic differentially methylated region (IG-DMR) located between Dlk1 and the adjacent non-coding-RNA gene Gtl2 (refs 2, 24, 25 ). This germlinederived mark, characterized by hypomethylation on the maternal LETTER RESEARCH chromosome 25 , is required for the acquisition of differential methylation after fertilization at the secondary Gtl2-DMR, which is at the Gtl2 promoter. Paternal IG-DMR methylation is required for expression of Dlk1 and repression of Gtl2 on the paternally inherited chromosome 26 .
We measured methylation at these DMRs and found no change at the Gtl2-DMR, consistent with retention of its imprinting. In contrast, hypermethylation at the IG-DMR was observed in NSCs and niche astrocytes, indicating that absence of Dlk1 imprinting is associated with postnatal gain of methylation at the germline DMR (Fig. 4f, g and Supplementary Fig. 7a, b) .
Our data support a role for DLK1 in a neurogenic continuum, initiating at the early postnatal period and being maintained over the lifetime of the ageing animal ( Supplementary Fig. 8 ). Compromised neurogenesis seems to be driven by an early increase, followed by a depletion, of the stem-cell pool. In the postnatal SVZ, soluble DLK1 derived from niche astrocytes signals through a membrane-bound form of DLK1 in NSCs to regulate stem-cell number, with a continued requirement for DLK1 in their maintenance with age. Notably, our findings indicate that NSCs and niche astrocytes are distinguished shortly after birth by expression of DLK1 membrane-bound and secreted isoforms, respectively, and that differential processing of a single gene confers distinct functional properties to these two cell types. Also noteworthy is the epigenetically regulated selective absence of imprinting, resulting in a biallelic dosage of Dlk1, which is required for normal neurogenesis. Biallelic expression of imprinted genes in specific cell types may constitute an important regulatory event in their developmental programme. The possibility that loss or gain of genomic imprinting might be used as a dynamic developmental mechanism to control gene dosage has wider implications for our understanding of the function and evolution of imprinting, and indicates that the epigenetic mechanisms that control the process in somatic lineages may be adaptable to the environmental niche in which they are acting.
METHODS SUMMARY
Dlk1-mutant and transgenic mice were maintained as previously described 11, 15 . For immunohistochemistry, vibratome sections from brains fixed in 4% paraformaldehyde were used. Neurosphere and primary astrocyte cultures were established as previously described 6, 8 . DLK1 recombinant protein (ENZO Life Sciences) was added to medium at the time of seeding. For co-culture experiments, a transwell insert (Millipore) was used and dissociated NSCs were seeded in the upper compartment. Neurospheres were nucleofected using a mouse NSC nucleofector kit (Amaxa Biosystems), as previously described 23 . Constructs used were pIRES-GFP empty vector (Invitrogen), pIRES-GFP-S-DLK1 or pIRES-GFP-MB-DLK1. Cells were seeded 48 h after nucleofection for neurosphere assessment and immunocytochemistry, as previously described 18 . Antibodies used are listed in Methods. For quantitative PCR using SYBR Green, RNA was isolated with Trizol (Invitrogen) and reverse-transcribed using SuperScript II RT (Invitrogen). Imprinting assays were based on PCR amplification and sequencing of samples derived from reciprocal F1 hybrid offspring of Mus musculus domesticus (C57BL/6) and Mus musculus castaneus (CAST/EiJ). Bisulphite mutagenesis-based cytosine methylation analysis was conducted as described previously 24 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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METHODS
Animals and in vivo manipulations. The generation and genotyping of Dlk1-mutant and transgenic mice have been described previously 11, 15 . Except for hybrid analyses, experiments were done with mice on a C57BL/6 genetic background and their corresponding wild-type littermates. Housing of mice and all experiments were carried out in accordance with UK Government Home Office licensing procedures. Tissue preparation and immunohistochemistry. BrdU administration regimes have been previously detailed 18 . Mice at 2-4 months of age were injected intraperitoneally with 50 mg of BrdU per kg of body weight every 2 h for 12 consecutive hours (7 injections in total). Thirty days after the injections, animals were deeply anaesthetized and transcardially perfused with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4 (PB), and their brains were vibratome-sectioned at 40 mm. The sections were blocked in 10% FBS (v/v, Invitrogen) and 0.1% Triton X-100 (v/v) in PBS (0.9% NaCl in PB) for 1 h, then incubated overnight with primary antibody at 4 uC. For embryonic studies, pregnant females were injected intraperitoneally with a single injection of 100 mg kg 21 BrdU and embryos (E12.5 and E14.5) were collected 1 h later. Embryonic and postnatal brains were dissected in PBS and fixed for 2 h in 4% PFA at 4 uC. Fixed samples were cryoprotected overnight in 20% sucrose in PBS at 4 uC, mounted in OCT Compound (VWR) and sectioned coronally (20 mm) with a cryostat (CM3050S, Leica). For immunohistochemistry, cryostat sections were washed in PBS and blocked at at 22 uC for 1 h in PBST (PBS, 0.1% Triton X-100) supplemented with 10% goat serum (Vector Laboratories). The primary antibodies and dilutions used were: mouse antibodies to BrdU (1:250; Dako), MKI67 (1:200; Novocastra), bIII-tubulin (1:250; Covance), NESTIN (1:500, Chemicon) or MASH1 (1:100; Beckton Dickinson); goat antibodies to SOX2 (1:100; R&D Systems) or DCX (1:300; Santa Cruz); rabbit antibodies to GFAP (1:500; Dako), S100b (1:100, Dako), TH (1:2,000; Sigma), CALB2 (1:4,000; Swant) or phosphorylated histone H3 (1:500; Upstate); rat antibody to DLK1 (1:100; ENZO Life Sciences). For detection of ependymal cells in vivo, sections were labelled with fluorescein isothiocyanate (FITC)-conjugated lectin IB4 (1:1,000; Sigma). For BrdU detection, sections were pre-incubated in 2 M HCl for 30 min at 37 uC and neutralized in 0.1 M sodium borate (pH 8.5). Secondary antibodies were Alexa-488-conjugated donkey anti-mouse, Alexa-488-conjugated anti-rat, Alexa-647-conjugated donkey anti-rabbit (Molecular Probes) and CY3-conjugated donkey anti-goat (Jackson ImmunoResearch Laboratories). These were used at 1:500 for 1 h. Nuclei were counterstained with 1 mg ml 21 DAPI. For DLK1 staining, Dlk1 2/2 SVZ sections or cultures were used to confirm antibody specificity. Immunofluorescence was analysed using a Leica Multispectral confocal microscope (Leica).
For SVZ whole-mounts, we used protocols established previously 27 . Briefly, the lateral walls of the lateral ventricle were dissected out and the resulting whole-mounts were fixed for 1.5 h in 4% paraformaldehyde and washed overnight at 4 uC in PBS. For DCX staining, whole-mounts were washed three times in PBS containing 0.5% Triton X-100 for 15 min each, blocked for 2 h in blocking solution (10% FBS (v/v) and 0.5% Triton X-100 (v/v) in PBS), then incubated for 72 h at 4 uC in goat anti-DCX (1:500; Santa Cruz). The secondary antibody, Alexa-488-conjugated anti-goat (Jackson ImmunoResearch Laboratories), was used at 1:500 dilution. The stained walls were mounted with Fluorsave (Calbiochem) between two coverslips. Neural stem-cell and primary astrocyte cultures. Methods for NSC culture and self-renewal assessment, as well as BrdU immunocytochemistry in neurosphere cultures, have been described previously in detail 18 . Single cells from SVZ dissociates were seeded at very low density (2.5 cells ml
21
) in neurosphere growth medium with epidermal growth factor (EGF) and fibroblast growth factor (FGF), supplemented with either recombinant DLK1 (mouse) fused to Fc (human) (2-100 ng ml 21 , produced in HEK-293 cells; ENZO Life Sciences), Jagged 1 (1 mg ml 21 ; Calbiochem), or PEDF (50 ng ml
; Bioproducts MD). The cultures were then analysed for formation of primary neurospheres after 5 days in vitro. For selfrenewal assays, primary spheres formed in any condition were treated with Accutase (0.5 mM; Sigma) for 10 min, mechanically dissociated to a single-cell suspension and re-plated in growth medium containing epidermal growth factor and fibroblast growth factor. Apoptosis and viability in single cells and incipient neurospheres were determined at 24 h and 72 h after plating, as previously described 23 . Multipotency capacity was analysed by seeding individual neurospheres of similar sizes at passage 2-3 in Matrigel-coated 96-well plates for 7 days in vitro (with 2% FBS, v/v), before fixation in 4% PFA. No fewer than 50 clones were analysed for each condition and the experiment was conducted as previously described 23 . 21 transferrin, supplemented with 10% FBS). Single-cell suspensions from the SVZ were seeded onto Matrigel-treated wells (31 Matrigel; Becton Dickinson) in astrocyte medium and cultured at 37 uC with 5% CO 2 until astrocytes reached confluence (approximately 6 days). The medium was changed every 2 days. The flasks were then shaken at 100 rotations min 21 for 3 h at 22 uC to shake off proliferating cells, oligodendrocyte progenitors and neurons. For co-culture experiments, the astrocyte culture medium was changed to neurosphere growth medium with mitogens, and 2 h afterwards, a transwell insert (0.4-mm pore, 12-mm diameter; Millipore) was placed above and dissociated NSCs were seeded in the upper compartment. The astrocyte purity of the cultures was established by immunostaining for GFAP. Primary antibodies and dilutions used in vitro were: mouse antibodies to BrdU (1:500; Dako), O4 (1:2, Developmental Studies Hybridoma Bank) or bIII-tubulin (1:300; Covance); rabbit antibodies to GFAP (1:700; Dako), NICD (1:200, Abcam) or caspase 3 (1:300, Cell Signaling); rat anti-DLK1 (1:100; ENZO Life Sciences). Secondary antibodies were Alexa-488-conjugated donkey anti-mouse, Alexa-488-conjugated anti-rat, Alexa-647-conjugated donkey antirabbit (Molecular Probes) and CY3-conjugated donkey anti-goat (Jackson ImmunoResearch Laboratories). Secondary antibodies were used at 1:500 for 1 h. DAPI (1 mg ml
) was used for counterstaining. Cell transduction and luciferase assays. Constructs encoding the predominant forms of Dlk1 that are generated by alternate splicing and proteolysis were generated previously 21 . We subcloned them in a pIRESh-GFPII vector (Invitrogen). NSCs grown for 2 days (passage 4-6) were nucleofected using a Mouse NSC nucleofector kit (Amaxa Biosystems), as described by the manufacturer, with 2-4 mg pIRESh-GFPII empty vector, pIRESh-GFPII-S-DLK1 (S-DLK1, the secreted form, contains sequences from full-length Dlk1A up to the juxtamembrane cleavage domain, amino acid 303), or pIRESh-GFPII-MB-DLK1 (MB-DLK1, the membrane-bound form, lacks the coding sequence for the juxtamembrane motif, amino acids 230-303, that is the substrate for cleavage, and so represents Dlk1C). Cells were dissociated 2 days after nucleofection and seeded at low density (2.5 cells ml
) in 96-well plates for neurosphere assessment. In reporter assays with a firefly-luciferase-based construct, we electroporated 2-4 mg of DNA from the construct 4xwtCBF1-luc 30 and 50 ng of a Renilla luciferase construct as an internal control. After 24-36 h, transduced cells (passage 4-6) were dissociated, plated in the presence or absence of DLK1 (50 ng ml
; ENZO Life Sciences) or PEDF (100 ng ml 21 ) as a positive control, then cultured for 24 h before being collected for analysis. Transfection efficiency was around 80% in all cases. Luciferase activity was measured in cell lysates using the Dual Luciferase Assay System (Promega) and promoter activity was defined as the ratio between the firefly and Renilla luciferase activities. Expression studies. RNAs were extracted with Trizol (Invitrogen), following the manufacturer's guidelines. For northern blots, mRNA was isolated from 75 mg of total RNA using the Dynabeads Oligo (dT) 25 kit (Invitrogen), following the manufacturer's protocol. We used probes described previously for Dlk1 and Gapdh 2 . For quantitative PCR, 1 mg of total RNA was DNase-treated with RQ1 RNase-free DNase (Promega), following the manufacturer's guidelines. All cDNA was synthesized using random primers and SuperScript II RT reverse transcriptase (Invitrogen), following standard procedures. Quantitative PCR was used to measure expression levels of Dlk1 normalized to Gapdh, and was performed on a DNA Engine 2 Opticon detection system (Bio-Rad) using SYBR Green I as a doublestrand-DNA-specific binding dye. Thermocycling was performed in a final volume of 20 ml, containing 2 ml of cDNA sample (diluted 1:5), 20 pmol of each primer (Dlk1-F, 59-GAAAGGACTGCCAGCACAAG-39; Dlk1-R, 39-CACAGA AGTTGCCTGAGAAGC-59; Gapdh-F, 59-CCATCACCATCTTCCAGGAG-39; Gapdh-R, 59-GCATGGACTGTGGTCATGAG-39), 2 mM MgCl 2 , 0.2 mM dNTP mixture, 31 Taq reaction buffer, 0.5 U HotStart Taq DNA polymerase and 0.5 ml of a 1:3,000 dilution of SYBR Green I. Semi-quantitative PCR was performed to determine the different Dlk1 isoforms, and levels of transcripts were quantified by densitometric analysis of PCR bands in electrophoresis gels stained with ethidium bromide, normalized to Gapdh levels obtained at 20 cycles. Primers used were: Dlk1Splice-F, 59-CTGCACACCTGGGTTCTCTG-39; DlkSplice-R, 39-TCCTCATCACCAGCCTCCTT-59. In situ hybridization was conducted on PFA-fixed 40-mm vibratome sections of adult brain, according to procedures previously described 15 . Imprinting assays. All imprinting assays were based on PCR amplification followed by direct sequencing to analyse parental-specific expression of the genes.
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